The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.
Drug prices outpace inflation, new study shows
By
Haymarket Media
Nov 16, 2005
Prices for brand-name drugs outpaced the rate of inflation over the past year, a new study shows.
Governors eye block grants as way to cut Medicaid costs
By
John O'Connor
Jul 01, 2011
House Republicans would like to see Medicaid outlays trimmed dramatically. And they are hardly alone.
Pharmacists push for study before implementing short-cycle dispensing rule
Mar 23, 2011
The National Community Pharmacists Association on Tuesday called for the Centers for Medicare & Medicaid Services to collect additional data before implementing a rule that would shorten the medication...
Medicare tops to-do list for lawmakers
Jan 14, 2008
Legislators are planning to resume discussions about Medicare after passing slimmed-down legislation on this program before the winter recess.
Flu vaccines ineffective in adults over 65, analyses assert
By
McKnight's Staff
Oct 26, 2012
A flurry of recent studies has shown that flu shots don’t offer much protection against influenza in elderly people who have received the vaccine, a recent report suggests.
CMS: Part D offerings to expand, prices won’t
By
Haymarket Media
Oct 03, 2006
Medicare Part D drug plan beneficiaries will have access to more changes next year — at this year’s prices, according to the Centers for Medicare & Medicaid Services.
President’s budget proposal cuts Medicaid payments to providers by $28.8 billion over 10 years
Feb 15, 2011
President Obama released his $3.7 trillion budget for FY 2012 Monday, and it would lower Medicaid payments to healthcare providers by $28.8 billion over 10 years.
Survey: Prices for seniors’ drugs rise twice as fast (again)
By
Haymarket Media
Aug 17, 2005
The average prices of drugs that elderly Americans use most often rose more than twice as fast as general inflation last year, according to survey results released Tuesday. It’s the third straight...
AARP: High drug costs could hurt benefits of Part D program
By
Haymarket Media
Apr 14, 2005
Wholesale prices for brand-name prescription drugs are rising so high they might work against the benefits of the new drug benefit that is expected to take effect this January, according to AARP, which...